Evidence map›Paper›PMID 34764608›Full record

ArticleApplied intelligence (Dordrecht, Netherlands)2022

Cross-sectional analysis and data-driven forecasting of confirmed COVID-19 cases.

Nan Jing, Zijing Shi, Yi Hu, Ji Yuan

Abstract read
In one paragraph

Article in Applied intelligence (Dordrecht, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. COVID-19 Patterns in Araraquara, Brazil: A Multimodal Analysis.International journal of environmental research and public health · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nan JingSHU-UTS SILC Business School, Shanghai University, Shanghai, 201800 China.
Zijing ShiSHU-UTS SILC Business School, Shanghai University, Shanghai, 201800 China.
Yi HuSHU-UTS SILC Business School, Shanghai University, Shanghai, 201800 China.
Ji YuanOnewo Space-Tech Service Co., Ltd., Shenzhen, 518049 China.ORCID 0000-0002-4369-647X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) is rapidly becoming one of the leading causes for mortality worldwide. Various models have been built in previous works to study the spread characteristics and trends of the COVID-19 pandemic. Nevertheless, due to the limited information and data source, the understanding of the spread and impact of the COVID-19 pandemic is still restricted. Therefore, within this paper not only daily historical time-series data of COVID-19 have been taken into account during the modeling, but also regional attributes, e.g., geographic and local factors, which may have played an important role on the confirmed COVID-19 cases in certain regions. In this regard, this study then conducts a comprehensive cross-sectional analysis and data-driven forecasting on this pandemic. The critical features, which has the significant influence on the infection rate of COVID-19, is determined by employing XGB (eXtreme Gradient Boosting) algorithm and SHAP (SHapley Additive exPlanation) and the comparison is carried out by utilizing the RF (Random Forest) and LGB (Light Gradient Boosting) models. To forecast the number of confirmed COVID-19 cases more accurately, a Dual-Stage Attention-Based Recurrent Neural Network (DA-RNN) is applied in this paper. This model has better performance than SVR (Support Vector Regression) and the encoder-decoder network on the experimental dataset. And the model performance is evaluated in the light of three statistic metrics, i.e. MAE, RMSE and

Indexed as

Coronavirus disease 2019 (COVID-19)Dual-stage attention-based recurrent neural network (DA-RNN)eXtreme gradient boosting (XGB)SHapley additive exPlanation (SHAP)

Identifiers

PMID34764608
PMCPMC8256957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.